- Published at
- by smallcaps.com.au
negative
negative
Imagion Biosystems advances MagSense HER2 imaging agent with FDA application
Cancer detection specialist Imagion Biosystems (ASX: IBX) has taken the next step in progressing its MagSense HER2 imaging agent, lodging an application